Lux Capital

Activity from announced rounds

Activity in this selectionOct 24, 2026 · North America · Jul 27, 2026

Lux Capital invests in companies emerging from the life sciences, physical sciences and computational sciences, including biotechnology, robotics, aerospace, defence and AI infrastructure.

Its investment approach includes small Seeds, Experiments and Optionality investments that let it engage with technology before a conventional venture case is established. The firm also makes thesis-driven investments and backs founders working on technically difficult problems.

Lux’s Riskgaming programme uses researched scenarios to examine how technological developments interact with geopolitics and national security. That perspective is especially relevant for founders whose commercial opportunity depends on scientific progress, industrial adoption or government demand.

Sources
Rounds participated in
13
Confirmed lead rounds
2
4 roles undisclosed
New companies
11
First participation on record · 2 follow-on
Funding in participating rounds
$4.5B
12 disclosed · full round size, not this investor’s share

By stage

Series C+5
Seed3
Series A2
Series B2
Growth1

By primary sector

Biotech3
AI2
Defense tech2
Space tech2
Climate tech1
3 more
Fintech1
Media & gaming1
Robotics1

By country

United States13

Rounds

13 in this selection
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A
Participant
Warhound

Warhound develops working dogs for military, law-enforcement and emergency-response teams.

$200MSeed
Participant
Flapping Airplanes

AI research company developing more efficient model training, GPU execution and inference.

$1BSeries A
Lead
Modal Labs

Optimizes AI inference to reduce compute costs and response time

$750MSeries D
Participant
Multiply Labs

Multiply Labs builds robotics for manufacturing personalized medicines, helping drug makers produce individualized treatments with less manual work.

$75MSeries B
Participant
Varda

Varda builds spacecraft that manufacture materials in low Earth orbit and return them to Earth. Its capsules support microgravity pharmaceutical development and materials processing, followed by controlled reentry and post-flight analysis of returned payloads.

$251MSeries D
Lead
Enveda

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

$311MSeries E
Participant
Impulse Space

Builds highly maneuverable orbital transfer vehicles and kick stages for in-space mobility and satellite logistics

$308MSeries D extension
Role not disclosed
Archive

A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content.

UndisclosedGrowth investment
Participant
Multiplier

Builds AI agent harnesses for asset managers' proprietary research and data

$6MSeed
Role not disclosed
Transfyr

Physical AI platform capturing real-world lab science into machine-readable data

$25MSeed
Role not disclosed
Hadrian

Builds highly automated factories producing defense and aerospace systems

$1.4BSeries D
Participant
WindBorne Systems

Operates autonomous sensing balloons and AI models for weather forecasting infrastructure

$37MSeries B
Role not disclosed